Metagenomic Insights Into the Subgingival Microbiome in Periodontal Health and Different Grades of Periodontitis
Journal of Periodontal Research · 2025
DOI: 10.1111/jre.13408 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Periodontal Research, 2025. Verfasst von Yan Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, …. Hauptthemen laut MEDLINE: Gingiva, Metagenomics, Microbiota, Periodontitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Postdoctoral Science Foundation of China, National Natural Science Foundation of China, the Science Fund for Distinguished Young Scholars of Zhejiang Province.
Abstract (Originalsprache)
Aim
This cross‐sectional study compared the subgingival microbiome in periodontal health (PH) and periodontitis, focusing on distinguishing Stage III Grade B periodontitis (PD‐S3gB) and Stage III Grade C periodontitis (PD‐S3gC) as defined by the 2018 Classification of Periodontitis.
Methods
Subgingival samples from subjects with PH, PD‐S3gB, and PD‐S3gC were analyzed using metagenomic sequencing. Taxonomic and functional annotations were performed, followed by analyses of microbial diversity, differential abundance, interspecies networks, predictive modeling, and functional pathway enrichment.
Results
Significant differences in both alpha and beta diversity were observed between PH and periodontitis. Several periodontal pathogens were more abundant in disease states, with Capnocytophaga granulosa and Capnocytophaga sp. CM59 enriched in PD‐S3gC compared to PD‐S3gB. The PD‐S3gC group also exhibited a more complex microbial network with increased interspecies connectivity. An 11‐species diagnostic model effectively distinguished PH, PD‐S3gB, and PD‐S3gC. Furthermore, pathways related to motility, chemotaxis, and methane metabolism were significantly enriched in periodontitis.
Conclusion
Distinct structural and functional differences in the subgingival microbiome characterize periodontal health and periodontitis. Periodontitis with a rapid rate of progression is marked by specific pathogen overgrowth and enhanced microbial interactions, supporting the development of microbiome‐based diagnostics and personalized therapies. Trial Registration: Chinese Clinical Trial Registration: ChiCTR2000039426
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cance…
ORCID-Profile: Pei-Hui Ding
Förderung
- Postdoctoral Science Foundation of China
- National Natural Science Foundation of China
- the Science Fund for Distinguished Young Scholars of Zhejiang Province
- National Key Research and Development Program of China
- Key Research and Development Program of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- Science Fund for Distinguished Young Scholars of Zhejiang Province
Zitieren
APA
Zhao, Y., Song, L., Li, H. Y., Liu, S. X., Mao, F. F., Li, X. J., & Ding, P. H. (2025). Metagenomic Insights Into the Subgingival Microbiome in Periodontal Health and Different Grades of Periodontitis. Journal of Periodontal Research. https://doi.org/10.1111/jre.13408
Vancouver
Zhao Y, Song L, Li HY, Liu SX, Mao FF, Li XJ, et al. Metagenomic Insights Into the Subgingival Microbiome in Periodontal Health and Different Grades of Periodontitis. Journal of Periodontal Research. 2025. doi:10.1111/jre.13408
BibTeX
@article{Zhao2025,
author = {Zhao, Yan and Song, Lu and Li, Hao-Yu and Liu, Shu-Xin and Mao, Fei-Fei and Li, Xiao-Jun and Ding, Pei-Hui},
title = {Metagenomic Insights Into the Subgingival Microbiome in Periodontal Health and Different Grades of Periodontitis},
journal = {Journal of Periodontal Research},
year = {2025},
doi = {10.1111/jre.13408}
}
EUVIMED